Please assess the completion status of the following clinical trial:

Trial Title: Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of breast cancer~* Experiencing 2 or more hot flashes per day for at least 1 week~* Hormone receptor status:~  * Not specified~PATIENT CHARACTERISTICS:~Age:~* Not specified~Sex:~* Female~Menopausal status:~* Not specified~Performance status:~* Not specified~Life expectancy:~* Not specified~Hematopoietic:~* Not specified~Hepatic:~* Bilirubin normal~* SGOT no greater than 2 times upper limit of normal (ULN)~Renal:~* Creatinine no greater than 1.25 times ULN~Cardiovascular:~* No coronary insufficiency~* No myocardial infarction within the past 3 months~* No symptomatic cardiac disease~* No peripheral vascular disease~* No cerebrovascular disease or stroke~* No syncope or symptomatic hypotension~Other:~* No history of allergic or other adverse reaction to gabapentin~* Not pregnant or nursing~* Fertile patients must use effective contraception during and for 1 week after study~PRIOR CONCURRENT THERAPY:~Biologic therapy~* Not specified~Chemotherapy~* Not specified~Endocrine therapy~* Not specified~Radiotherapy~* Not specified~Surgery~* Not specified~Other~* No other concurrent anticonvulsant medication~* No concurrent clonidine or venlafaxine

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: 120 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).